Sang Froid labs India receives drug license

17 Oct 2018 Evaluate

Sang Froid labs India has received license to sell, stock or exhibit or offer for sale, or distribute by Wholesale drugs specified in Schedules C and C(1) [excluding those specified In schedule x] as per the Drugs and Cosmetics Rules, 1945 in form 21B and the company has received license to sell, stock or exhibit or offer for sale, or distribute by Wholesale drugs specified Other Than Those Specified in Schedules C and C(1) and in schedule x as per the Drugs and Cosmetics Rules, 1945 in form 20B at the premises situated at F-118, Signature Complex ,Sur No.340, TP No.38, FP no. 223,224 Opposite Suvarna Bung, 100 Ft Hebatpur Road, Thaltej, Ahmedabad, Further the license shall be in force from October 12, 2018 to October 11, 2023.

The main objects of the company for which it was incorporated were to import/export , buy/ and deal in pharmaceutical medicines, drug intermediates, bulk drugs, medical preparations, surgical instruments, X-ray equipments, cat scanner, ultrasound equipments, blood testing equipments and all other hospital related equipment.

Sang Froid Labs Share Price

1.32 0.00 (0.00%)
25-Nov-2019 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×